Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

NCT00052754 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

NETWORK

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: gefitinib

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC